Join us at this year's SCOPE Summit 2026 in Barcelona, Spain.
HTA and Reimbursement Submissions
The reimbursement environment is constantly changing. Requirements vary between markets and need coordination across multiple areas to produce high-quality results. Our experts in value, access, and health economics have experience contributing to successful submissions in many countries and across therapeutic areas. Our integrated team approach can help you achieve the best result for your product.
Comparing Health Economic Evaluations of Medical Technologies by HTA Bodies
Resource Type
Video
RTI-HS analyzed how HTA bodies assess medical technologies, revealing key differences and similarities in health economic evaluation methods worldwide.
I continue to really enjoy working with RTI. This is a well rounded team that provides quality outputs that we can rely on. The team is friendly, focused, timely and efficient.
HTA and Reimbursement Submission Services
We can support pharmaceutical and medtech companies with comprehensive HTA and reimbursement submission services to help you navigate complex global market access requirements, offering strategic guidance, technical expertise, and full-spectrum support across clinical, economic, and regulatory domains.
HTA Submissions
Strategic and technical expertise to help you develop and submit high-quality health technology assessment (HTA) and reimbursement dossiers for global market access.
AMCP Dossiers
Standardized AMCP dossiers present evidence of your product’s value to support formulary decisions by U.S. healthcare payers
Global Value Dossiers
Comprehensive, evidence-based deliverables that communicate the clinical, humanistic, and economic value of your product to diverse stakeholders
Decision-Analytic Models
Decision-analytic models provide a framework for compiling clinical and economic evidence in a systematic fashion, determining your product’s value, and communicating that value to decision makers.
Literature Reviews
Synthesize existing scientific findings to help you evaluate current knowledge, identify gaps, and inform development decisions
Utility Assessment
Measure patient preferences to generate utility scores that strengthen economic models and inform healthcare resource decisions. Learn more.
Health Equity
Bridge equity and innovation across the pharmaceutical lifecycle
ICER Support
Proactively protect value, optimize pricing, and ensure your therapy aligns with ICER’s evolving landscape
Expert Perspective Research
Navigate the complexities of pricing, reimbursement, and access to ensure your product meets the expectations of decision-makers worldwide
Value Communication Materials
Ensure your research findings and value messages can be adopted by relevant audiences with high-impact communication tools
HTA and Reimbursement Submission Resources
Oct 26 - 28, '26
Join us for our presentation at this year's WODC EU and meet our team at booth #315.
Session: Oct 27 16:10
Nov 8 - 11, '26
Bruno-Kreisky-Platz 1
1220 Vienna
Austria
We are pleased to be a year-round sponsor of ISPOR. Our team will attend, speak, and present in Vienna—see details here.